Children
Pediatric neurofeedback: developmental support, learning issues, behavioral challenges, and family-centered care.
18 itemsGet Started →
Blog Articles
Research Papers
Showing 6 of 17Brain training with neurofeedback in patients with mild cognitive impairment: a review study
Arroyo-Alvis, Katy Estela, Allegri, Ricardo Francisco, Barcelo Martínez, Ernesto Alejandro (2022) · Gaceta Médica de Caracas
Objective: The study aimed to establish the differences in the levels of adaptation, social support, and perceived family functionality according to sex, age, and school grade of a sample of 160 children and adolescents affected by floods in the Mojana sub-region of the Department of Sucre, Colombia.
View Full Paper →Results of Neurofeedback in Treatment of Children with ADHD: A Systematic Review of Randomized Controlled Trials
Moreno-García, Inmaculada, Cano-Crespo, Almudena, Rivera, Francisco (2022) · Applied Psychophysiology and Biofeedback
Attention-deficit/hyperactivity disorder (ADHD) is one of the most prevalent disorders in children and adolescents. Neurofeedback, a nonpharmaceutical treatment, has shown promising results. To review the evidence of efficacy of neurofeedback as a treatment for children and adolescents with ADHD. A systematic review of the specific scientific studies published in 1995–2021, identifying and analyzing randomized controlled trials (RCT). A total of 1636 articles were identified and 165 met inclusion criteria, of which 67 were RCTs. Neurofeedback training was associated with significant long-term reduction in symptoms of ADHD. Though limitations exist regarding conclusions about the specific effects of neurofeedback, the review documents improvements in school, social, and family environments.
View Full Paper →Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review
Correll, Christoph U., Cortese, Samuele, Croatto, Giovanni, Monaco, Francesco, Krinitski, Damir, Arrondo, Gonzalo, Ostinelli, Edoardo G., Zangani, Caroline, Fornaro, Michele, Estradé, Andrés, Fusar‐Poli, Paolo, Carvalho, Andre F., Solmi, Marco (2021) · World Psychiatry
Top‐tier evidence on the safety/tolerability of 80 medications in children/adolescents with mental disorders has recently been reviewed in this journal. To guide clinical practice, such data must be combined with evidence on efficacy and acceptability. Besides medications, psychosocial interventions and brain stimulation techniques are treatment options for children/adolescents with mental disorders. For this umbrella review, we systematically searched network meta‐analyses (NMAs) and meta‐analyses (MAs) of randomized controlled trials (RCTs) evaluating 48 medications, 20 psychosocial interventions, and four brain stimulation techniques in children/adolescents with 52 different mental disorders or groups of mental disorders, reporting on 20 different efficacy/acceptability outcomes. Co‐primary outcomes were disease‐specific symptom reduction and all‐cause discontinuation (“acceptability”). We included 14 NMAs and 90 MAs, reporting on 15 mental disorders or groups of mental disorders. Overall, 21 medications outperformed placebo regarding the co‐primary outcomes, and three psychosocial interventions did so (while seven outperformed waiting list/no treatment). Based on the meta‐analytic evidence, the most convincing efficacy profile emerged for amphetamines, methylphenidate and, to a smaller extent, behavioral therapy in attention‐deficit/hyperactivity disorder; aripiprazole, risperidone and several psychosocial interventions in autism; risperidone and behavioral interventions in disruptive behavior disorders; several antipsychotics in schizophrenia spectrum disorders; fluoxetine, the combination of fluoxetine and cognitive behavioral therapy (CBT), and interpersonal therapy in depression; aripiprazole in mania; fluoxetine and group CBT in anxiety disorders; fluoxetine/selective serotonin reuptake inhibitors, CBT, and behavioral therapy with exposure and response prevention in obsessive‐compulsive disorder; CBT in post‐traumatic stress disorder; imipramine and alarm behavioral intervention in enuresis; behavioral therapy in encopresis; and family therapy in anorexia nervosa. Results from this umbrella review of interventions for mental disorders in children/adolescents provide evidence‐based information for clinical decision making.
View Full Paper →The impact of neurofeedback training on children with developmental trauma: A randomized controlled study.
Rogel, Ainat, Loomis, Alysse M., Hamlin, Ed, Hodgdon, Hilary, Spinazzola, Joseph, van der Kolk, Bessel (2020) · Psychological Trauma: Theory, Research, Practice, and Policy
Abuse and neglect of children by caregivers often have long-lasting and pervasive effects on mental and neural development, including problems with attention, impulse control, self-regulation, and executive functioning. Impairment of affect regulation is thought to be the largest obstacle to effective intervention. In this pilot study of neurofeedback for polysymptomatic children with such histories, we found a significant improvement on affect regulation and executive functioning after 24 sessions of neurofeedback treatment. This offers the possibility of being able to improve learning, enhance self-efficacy, and develop better social relationships in this hitherto largely treatment resistant population.
View Full Paper →Near-infrared spectroscopy (NIRS) neurofeedback as a treatment for children with attention deficit hyperactivity disorder (ADHD)—a pilot study
Marx, Anna-Maria, Ehlis, Ann-Christine, Furdea, Adrian, Holtmann, Martin, Banaschewski, Tobias, Brandeis, Daniel, Rothenberger, Aribert, Gevensleben, Holger, Freitag, Christine M., Fuchsenberger, Yvonne, Fallgatter, Andreas J., Strehl, Ute (2015) · Frontiers in Human Neuroscience
In this pilot study near-infrared spectroscopy (NIRS) neurofeedback was investigated as a new method for the treatment of Attention Deficit-/Hyperactivity Disorder (ADHD). Oxygenated hemoglobin in the prefrontal cortex of children with ADHD was measured and fed back. 12 sessions of NIRS-neurofeedback were compared to the intermediate outcome after 12 sessions of EEG-neurofeedback (slow cortical potentials, SCP) and 12 sessions of EMG-feedback (muscular activity of left and right musculus supraspinatus). The task was either to increase or decrease hemodynamic activity in the prefrontal cortex (NIRS), to produce positive or negative shifts of SCP (EEG) or to increase or decrease muscular activity (EMG). In each group nine children with ADHD, aged 7–10 years, took part. Changes in parents’ ratings of ADHD symptoms were assessed before and after the 12 sessions and compared within and between groups. For the NIRS-group additional teachers’ ratings of ADHD symptoms, parents’ and teachers’ ratings of associated behavioral symptoms, childrens’ self reports on quality of life and a computer based attention task were conducted before, 4 weeks and 6 months after training. As primary outcome, ADHD symptoms decreased significantly 4 weeks and 6 months after the NIRS training, according to parents’ ratings. In teachers’ ratings of ADHD symptoms there was a significant reduction 4 weeks after the training. The performance in the computer based attention test improved significantly. Within-group comparisons after 12 sessionsof NIRS-, EEGand EMG-training revealed a significant reduction in ADHD symptoms in the NIRS-group and a trend for EEG and EMG-groups. No significant differences for symptom reduction were found between the groups. Despite the limitations of small groups and the comparison of a completed with two uncompleted interventions, theresults of this pilot study are promising. NIRS-neurofeedback could be a time-effective treatment for ADHD and an interesting new option to consider in the treatment of ADHD
View Full Paper →Effectiveness of Neurofeedback Therapy in Children with Separation Anxiety Disorder
Sadjadi, Seyed Alireza, Hashemian, P (2014) · Journal of Psychiatry
Background: Anxiety disorders are one of the most common psychiatric disorders in children. Its incidence is 2-5% of children and adolescents under age 18. Anxiety disorders are more common in girls than boys. It may start in pre-school, but mostly are in age of 7 to 8 years old. Method: The main objective of this article was to find out the effect of neurofeedback therapy in children with separation-anxiety disorder. Study population was Children from 7 to 12 years old with separation anxiety disorder who were referred to the child psychiatric clinic and they were divided randomly into two groups of 12. One group (N=12) received neurofeedback therapy and the other group (N=12) received sham neurofeedback therapy (placebo). Data was analyzed with t- test by 21th version SPSS software. Results: According to calculated t-test in neurofeedback group (8.18), neurofeedback was effective in reducing separation anxiety and the efficacy of treatment was great. But according to calculated t-test in sham group (4.42), reduction of separation anxiety was moderate. Therefore the efficacy of treatment in neurofeedback and sham groups was different. Conclusion: The results revealed that the efficacy of treatment of neurofeedback and sham groups on separation anxiety in children is different. Comparison of efficacy shows that effectiveness of neurofeedback treatment on separation anxiety was much more in the group treated with Neurofeedback than in the sham group.
View Full Paper →Ready to Optimize Your Brain?
Schedule a free consultation to discuss children and how neurofeedback training can help
Or call us directly at 855-88-BRAIN
View Programs & Pricing →